NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.45% | 10.75% | 18.68% | 25.27% | -74.03% |
| Total Depreciation and Amortization | -57.03% | -56.73% | -45.85% | -23.86% | -9.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 840.34% | -65.38% | -60.95% | -47.38% | -58.72% |
| Change in Net Operating Assets | -120.72% | -8.86% | -65.34% | 157.55% | -18.03% |
| Cash from Operations | 57.23% | -2.84% | -9.60% | 45.28% | -132.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 160.34% | -81.67% | -13.30% | -52.91% | -69.83% |
| Cash from Investing | 160.34% | -81.67% | -13.73% | -52.48% | -69.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.91% | -- | 58,051.35% | -- | 1,804.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.91% | -- | 54,745.95% | -- | 1,804.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.55% | -83.31% | 71,661.54% | -64.51% | -780.12% |